Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03259087
What this trial is testing

Pharmacokinetics (PK) and Safety of a Single Intravenous (IV) Dose of MK-3866 in Participants With Impaired Renal Function and in Healthy Controls (MK-3866-005)

Who this might be right for
Renal Impairment
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT01444872
What this trial is testing

Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction

Who this might be right for
Heart FailureKidney Disease
Trevena Inc. 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06630871
What this trial is testing

A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.

Who this might be right for
NMIBC
Fujian Medical University Union Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00498212
What this trial is testing

A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal Disease

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 41
Testing effectiveness (Phase 2)Ended earlyNCT04088500
What this trial is testing

Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Bristol-Myers Squibb 5
Early research (Phase 1)Study completedNCT01571999
What this trial is testing

Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 17
Early research (Phase 1)Looking for participantsNCT06186414
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SIM0237 Alone or in Combination with BCG in NMIBC

Who this might be right for
Non-Muscle-Invasive Bladder Cancer (NMIBC)
Jiangsu Simcere Pharmaceutical Co., Ltd. 152
Not applicableStudy completedNCT04650516
What this trial is testing

Endocare® (Single Care) in Pain-related Endometriosis

Who this might be right for
EndometriosisPain
Lucine 45
Early research (Phase 1)Study completedNCT03961932
What this trial is testing

Safety and Pharmacokinetics of Linzagolix in Female Subjects With Normal and Impaired Renal Function

Who this might be right for
Renal ImpairmentHealthy Participants
ObsEva SA 33
Testing effectiveness (Phase 2)Looking for participantsNCT03675893
What this trial is testing

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

Who this might be right for
Endometrial Cancer
Dana-Farber Cancer Institute 110
Post-approval studies (Phase 4)Ended earlyNCT00936247
What this trial is testing

Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)

Who this might be right for
Renal Insufficiency
B. Braun Melsungen AG 2
Early research (Phase 1)Study completedNCT04925284
What this trial is testing

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

Who this might be right for
Non Small Cell Lung CancerCervical CancerSCCHN+8 more
Exelixis 269
Not applicableStudy completedNCT07398014
What this trial is testing

The New Possibility of Treating Overactive Bladder With Radiofrequency

Who this might be right for
Overactive Bladder and Urge Urinary Incontinence
University Maribor 95
Not applicableStudy completedNCT03693638
What this trial is testing

Fractionated Vs Single Dose Injection for Spinal C-Section in Patients With Pregnancy-Induced Hypertension

Who this might be right for
Pregnancy Induced Hypertension
Universitas Indonesia 42
Early research (Phase 1)Study completedNCT03844555
What this trial is testing

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Who this might be right for
Renal ImpairmentRenal InsufficiencyKidney Diseases+1 more
Genfit 23
Testing effectiveness (Phase 2)Looking for participantsNCT07386158
What this trial is testing

Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC

Who this might be right for
VorolanibClear Cell Renal Cell Carcinoma (ccRCC)Neoadjuvant Therapy
Sun Yat-sen University 21
Not applicableStudy completedNCT03437538
What this trial is testing

Reduction Ratio and Clearance During Hemodialysis With MCO-filter Compared to HDF With Standard High-flux Filter

Who this might be right for
Chronic Kidney FailureUremiaDialysis
Region Skane 18
Early research (Phase 1)Study completedNCT01791855
What this trial is testing

PF-04634817 Renal Impairment Study

Who this might be right for
Renal Insufficiency
Pfizer 32
Testing effectiveness (Phase 2)Study completedNCT02674061
What this trial is testing

Efficacy and Safety Study of Pembrolizumab (MK-3475) in Participants With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 376
Testing effectiveness (Phase 2)Active Not RecruitingNCT05652283
What this trial is testing

Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Who this might be right for
Ovarian Cancer
Bai-Rong Xia 37
Next Page